These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 23849174)
1. Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. Touchefeu Y; Khan AA; Borst G; Zaidi SH; McLaughlin M; Roulstone V; Mansfield D; Kyula J; Pencavel T; Karapanagiotou EM; Clayton J; Federspiel MJ; Russell SJ; Garrett M; Collins I; Harrington KJ Radiother Oncol; 2013 Jul; 108(1):24-31. PubMed ID: 23849174 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair. Hingorani M; White CL; Zaidi S; Pandha HS; Melcher AA; Bhide SA; Nutting CM; Syrigos KN; Vile RG; Vassaux G; Harrington KJ Mol Ther; 2010 Sep; 18(9):1599-605. PubMed ID: 20588260 [TBL] [Abstract][Full Text] [Related]
3. Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy. Li H; Peng KW; Russell SJ Hum Gene Ther; 2012 Mar; 23(3):295-301. PubMed ID: 22235810 [TBL] [Abstract][Full Text] [Related]
4. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. Msaouel P; Iankov ID; Allen C; Aderca I; Federspiel MJ; Tindall DJ; Morris JC; Koutsilieris M; Russell SJ; Galanis E Mol Ther; 2009 Dec; 17(12):2041-8. PubMed ID: 19773744 [TBL] [Abstract][Full Text] [Related]
6. Effective radiovirotherapy for malignant gliomas by using oncolytic measles virus strains encoding the sodium iodide symporter (MV-NIS). Opyrchal M; Allen C; Iankov I; Aderca I; Schroeder M; Sarkaria J; Galanis E Hum Gene Ther; 2012 Apr; 23(4):419-27. PubMed ID: 22185260 [TBL] [Abstract][Full Text] [Related]
7. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962 [TBL] [Abstract][Full Text] [Related]
8. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Dingli D; Peng KW; Harvey ME; Greipp PR; O'Connor MK; Cattaneo R; Morris JC; Russell SJ Blood; 2004 Mar; 103(5):1641-6. PubMed ID: 14604966 [TBL] [Abstract][Full Text] [Related]
9. Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine. Hutzen B; Pierson CR; Russell SJ; Galanis E; Raffel C; Studebaker AW BMC Cancer; 2012 Nov; 12():508. PubMed ID: 23134812 [TBL] [Abstract][Full Text] [Related]
10. Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer. Penheiter AR; Wegman TR; Classic KL; Dingli D; Bender CE; Russell SJ; Carlson SK AJR Am J Roentgenol; 2010 Aug; 195(2):341-9. PubMed ID: 20651188 [TBL] [Abstract][Full Text] [Related]
12. Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer. Mansfield DC; Kyula JN; Rosenfelder N; Chao-Chu J; Kramer-Marek G; Khan AA; Roulstone V; McLaughlin M; Melcher AA; Vile RG; Pandha HS; Khoo V; Harrington KJ Gene Ther; 2016 Apr; 23(4):357-68. PubMed ID: 26814609 [TBL] [Abstract][Full Text] [Related]
13. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme. Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196 [TBL] [Abstract][Full Text] [Related]
14. Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy. Miest TS; Frenzke M; Cattaneo R Mol Ther; 2013 Nov; 21(11):2019-31. PubMed ID: 23913184 [TBL] [Abstract][Full Text] [Related]
15. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene. Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567 [TBL] [Abstract][Full Text] [Related]
16. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Li H; Peng KW; Dingli D; Kratzke RA; Russell SJ Cancer Gene Ther; 2010 Aug; 17(8):550-8. PubMed ID: 20379224 [TBL] [Abstract][Full Text] [Related]